|1.||Halperin, Scott A: 1 article (07/2004)|
|2.||Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC): 1 article (07/2004)|
|3.||Boucher, François D: 1 article (07/2004)|
|4.||Langley, Joanne M: 1 article (07/2004)|
|5.||Smith, Bruce: 1 article (07/2004)|
|6.||Mihalyi, J E: 1 article (08/2000)|
|7.||Wilson, W D: 1 article (08/2000)|
|8.||Marsh, A E: 1 article (08/2000)|
|9.||Lakritz, J: 1 article (08/2000)|
|1.||Whooping Cough (Pertussis)
07/01/1997 - "We conclude that 7 days of erythromycin estolate is as effective as 14 days for the eradication of B pertussis."
10/01/1999 - "Under the conditions of this study, erythromycin estolate prevented culture-positive pertussis in household contacts of patients with pertussis but did not prevent clinical pertussis."
11/01/1988 - "Because more studies have reported bacteriological and clinical relapses with ethylsuccinate and stearate formulations than with the estolate preparation, erythromycin estolate 50 mg/kg/d in divided doses over a 14-day period is recommended for the treatment of pertussis. "
07/01/1997 - "We randomly allocated children and adults with culture-positive community-acquired pertussis to either 7 or 14 days of erythromycin estolate treatment (40 mg/kg/d; maximum dose 1 g/d). "
11/01/1986 - "Erythromycin estolate for treatment of pertussis."
07/01/1997 - "Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections."
05/10/1971 - "[Erythromycin estolate in treatment of genital tract infections in obstetrics and gynecology]."
12/01/1961 - "[Experience in the use of Ilosone in acute infections in otorhinolaryngology]."
10/01/1999 - "A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection."
08/01/1988 - "Clinical trials are warranted in which these products are compared in infections other than Streptococcus pyogenes pharyngitis, for which the clinical superiority of erythromycin estolate has been demonstrated."
10/01/1966 - "[Clinico-bacteriological study on recent phlogogenic bacteria in acute otitis media and therapy with erythromycin estolate]."
01/01/1963 - "THERAPY WITH ERYTHROMYCIN ESTOLATE FOR OTITIS MEDIA ASSOCIATED WITH HAEMOPHILUS INFLUENZAE INFECTION."
07/01/1998 - "In this study in an outpatient setting in Germany, erythromycin estolate was as safe and effective as amoxicillin in the treatment of acute otitis media. "
07/01/1998 - "Therefore, a double-blind, randomized, multicenter trial was performed to compare the clinical efficacy and safety of erythromycin estolate versus amoxicillin in children with acute otitis media and to identify the risk factors associated with clinical failure. "
07/01/1998 - "Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. "
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/1981 - "Cefadroxil monohydrate, an oral cephalosporin with a long half-life, was compared to erythromycin estolate for efficacy in treating upper respiratory tract infections in children. "
08/01/1970 - "A comparison of the erythromycin estolate and tetracycline in the treatment of respiratory tract infections."
|6.||Erythromycin Ethylsuccinate (E-Mycin E)
|7.||Penicillin V (Phenoxymethylpenicillin)
|8.||Clavulanic Acid (Potassium Clavulanate)
|10.||Taurocholic Acid (Sodium Taurocholate)
|2.||Bone Transplantation (Bone Grafting)